Abstract
We retrospectively evaluated the usefulness of intravenous paticnt-controllcd analgesia (IV-PCA) on postoperative pain in patients undergoing surgery for oral and maxillofacial tumors in our hospital over the past 2 years. Thirteen patients who used IV-PCA with fentanyl following the removal of oral and maxillofacial tumors and/or reconstruction (> =4 operative hours) during the study period were recruited for the study (IV-PCA group). Thirteen patients who did not use IV-PCA following the same kinds of surgeries lasting over 4 hours during the same period served as a control group (non-IV-PCA group). The numeric rating scale of pain (NRS) was used as a pain score. The maximum NRS and postoperative complications until 24 hours after surgery were compared between the groups. For the statistical analysis, we used the unpaired t-Test, the Mann-Whitney test, or the chi-square test I a significant result was defined as p<0.05. No significant differences in the age, sex, height, weight, body mass index, duration of operation, or method of anesthesia were observed between the groups. The rate of patients with a maximum NRS of 4 or greater until 24 hours after surgery was significantly lower in the IV-PCA group than in the non-IV-PCA group. The occurrence of nausea and/or vomiting was noted in both groups, but there was no difference in the rate of occurrence between the groups. Furthermore, no severe complications occurred in the IV-PCA group, resulting in the discontinuation of IV-PCA. These results suggest that IV-PCA with fentanyl is a useful method against postoperative pain following surgery for oral and maxillofacial tumors.
| Original language | English |
|---|---|
| Pages (from-to) | 17-22 |
| Number of pages | 6 |
| Journal | Journal of Japanese Dental Society of Anesthesiology |
| Volume | 45 |
| Issue number | 1 |
| Publication status | Published - 2017 |
Fingerprint
Keywords
- Fentanyl
- Intravenous patient-controlled analgesia
- Oral and maxillofacial surgery
- Postoperative pain
ASJC Scopus subject areas
- Dentistry(all)
- Anesthesiology and Pain Medicine
Cite this
Effect of intravenous patient-controlled analgesia (IV-PCA) on postoperative pain in patients undergoing surgery for oral and maxillofacial tumors. / Miyake, Saki; Higuchi, Hitoshi; Onishi, Rieko; Tanimura, Hiroshi; Takaya, Kumiko; Honda, Yuka; Kawase, Akiko; Maeda, Shigeru; Miyawaki, Takuya.
In: Journal of Japanese Dental Society of Anesthesiology, Vol. 45, No. 1, 2017, p. 17-22.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Effect of intravenous patient-controlled analgesia (IV-PCA) on postoperative pain in patients undergoing surgery for oral and maxillofacial tumors
AU - Miyake, Saki
AU - Higuchi, Hitoshi
AU - Onishi, Rieko
AU - Tanimura, Hiroshi
AU - Takaya, Kumiko
AU - Honda, Yuka
AU - Kawase, Akiko
AU - Maeda, Shigeru
AU - Miyawaki, Takuya
PY - 2017
Y1 - 2017
N2 - We retrospectively evaluated the usefulness of intravenous paticnt-controllcd analgesia (IV-PCA) on postoperative pain in patients undergoing surgery for oral and maxillofacial tumors in our hospital over the past 2 years. Thirteen patients who used IV-PCA with fentanyl following the removal of oral and maxillofacial tumors and/or reconstruction (> =4 operative hours) during the study period were recruited for the study (IV-PCA group). Thirteen patients who did not use IV-PCA following the same kinds of surgeries lasting over 4 hours during the same period served as a control group (non-IV-PCA group). The numeric rating scale of pain (NRS) was used as a pain score. The maximum NRS and postoperative complications until 24 hours after surgery were compared between the groups. For the statistical analysis, we used the unpaired t-Test, the Mann-Whitney test, or the chi-square test I a significant result was defined as p<0.05. No significant differences in the age, sex, height, weight, body mass index, duration of operation, or method of anesthesia were observed between the groups. The rate of patients with a maximum NRS of 4 or greater until 24 hours after surgery was significantly lower in the IV-PCA group than in the non-IV-PCA group. The occurrence of nausea and/or vomiting was noted in both groups, but there was no difference in the rate of occurrence between the groups. Furthermore, no severe complications occurred in the IV-PCA group, resulting in the discontinuation of IV-PCA. These results suggest that IV-PCA with fentanyl is a useful method against postoperative pain following surgery for oral and maxillofacial tumors.
AB - We retrospectively evaluated the usefulness of intravenous paticnt-controllcd analgesia (IV-PCA) on postoperative pain in patients undergoing surgery for oral and maxillofacial tumors in our hospital over the past 2 years. Thirteen patients who used IV-PCA with fentanyl following the removal of oral and maxillofacial tumors and/or reconstruction (> =4 operative hours) during the study period were recruited for the study (IV-PCA group). Thirteen patients who did not use IV-PCA following the same kinds of surgeries lasting over 4 hours during the same period served as a control group (non-IV-PCA group). The numeric rating scale of pain (NRS) was used as a pain score. The maximum NRS and postoperative complications until 24 hours after surgery were compared between the groups. For the statistical analysis, we used the unpaired t-Test, the Mann-Whitney test, or the chi-square test I a significant result was defined as p<0.05. No significant differences in the age, sex, height, weight, body mass index, duration of operation, or method of anesthesia were observed between the groups. The rate of patients with a maximum NRS of 4 or greater until 24 hours after surgery was significantly lower in the IV-PCA group than in the non-IV-PCA group. The occurrence of nausea and/or vomiting was noted in both groups, but there was no difference in the rate of occurrence between the groups. Furthermore, no severe complications occurred in the IV-PCA group, resulting in the discontinuation of IV-PCA. These results suggest that IV-PCA with fentanyl is a useful method against postoperative pain following surgery for oral and maxillofacial tumors.
KW - Fentanyl
KW - Intravenous patient-controlled analgesia
KW - Oral and maxillofacial surgery
KW - Postoperative pain
UR - http://www.scopus.com/inward/record.url?scp=85016438956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016438956&partnerID=8YFLogxK
M3 - Article
VL - 45
SP - 17
EP - 22
JO - Journal of Japanese Dental Society of Anesthesiology
JF - Journal of Japanese Dental Society of Anesthesiology
SN - 0386-5835
IS - 1
ER -